The European Commission has approved a contract with BioNTech-Pfizer for the supply of another 1.8 billion doses of coronavirus vaccine in 2021-2023, of which half is guaranteed supplies.
This was stated by the President of the European Commission, Ursula von der Leyen.
вЂњI am pleased to announce that the European Commission has just approved a contract for guaranteed 900 million doses of the vaccine and the possibility of (supplying) another 900 million doses with BioNTech-Pfizer for 2021-2023,вЂќ she said.
The agreement between the EU and the companies was announced at the end of April. The agreement should provide the doses required for revaccination.
Recall that recently the BioNTech-Pfizer vaccine was submitted to the EU regulator for approval for use for adolescents 12-15 years old.
BioN-Tech-Pfizer is one of four coronavirus vaccines that have received conditional approval from the EU regulator, alongside Moderna, AstraZeneca, and Johnson & Johnson.
According to the latest data from the European Center for Disease Prevention and Control, 31.3% of adults in the EU received the first dose of coronavirus vaccination, and 11.9% received both doses.